Welcome to our dedicated page for TRIO-TECH INTERNATIONAL SEC filings (Ticker: TRT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on TRIO-TECH INTERNATIONAL's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into TRIO-TECH INTERNATIONAL's regulatory disclosures and financial reporting.
Trio-Tech International reported that its Board of Directors approved Third Amended and Restated Bylaws effective July 7, 2026. The revisions add detailed notice and procedural requirements for shareholder director nominations and other business, and expressly incorporate the universal proxy rules under Rule 14a-19.
The bylaws also adopt exclusive forum provisions, designating the Superior Court of California, County of Los Angeles as the forum for derivative and fiduciary-duty claims and certain corporate law matters, with a federal fallback, and designating federal district courts as the exclusive forum for claims under the Securities Act of 1933.
TRIO-TECH INTERNATIONAL senior corporate vice president and COO (Testing) Lim Hwee Poh received a grant of stock options covering 5,000 shares of common stock. The options have an exercise price of $9.74 per share and expire on July 6, 2031. According to the footnote, 1,250 of these options vest on the grant date, with the remaining 3,750 vesting in three equal annual installments thereafter. Following this award, the filing shows 5,000 derivative securities held directly.
TRIO-TECH INTERNATIONAL reported a Form 4 for Chief Financial Officer Anitha Srinivasan showing a grant of stock options. She acquired derivative rights to buy 5,000 shares of common stock at an exercise price of $9.74 per share, expiring on July 6, 2031. According to the footnote, 1,250 options vest immediately on the grant date, with the remaining options vesting in three equal annual installments. Following this compensation award, she holds 5,000 derivative securities directly.
Trio‑Tech International director Richard M. Horowitz filed an amended Schedule 13D reporting his ownership in the company’s common stock. He may be deemed to beneficially own 902,353 shares, including 237,569 options exercisable within 60 days, representing approximately 8.6% of the outstanding shares based on 10,298,449 shares as of June 18, 2026.
Horowitz holds the position for investment purposes and states he has no current plans related to major corporate actions such as mergers, recapitalizations, or changes in control. The filing notes that on December 16, 2025 he gifted 40,000 shares to trusts in which he has no beneficial interest, and on May 18, 2026 he disposed of 67,500 shares in an open‑market sale at a weighted average price of $18.1003 per share. He retains sole voting and dispositive power over his reported holdings and may buy or sell additional securities in the future subject to applicable laws.
TRIO-TECH INTERNATIONAL director Jason T. Adelman reported option exercises and share sales. On June 23, 2026, he exercised derivative securities to acquire 70,000 shares of Common Stock at an exercise price of $3.11 per share, increasing his direct holdings.
Before that, he completed open-market sales of 5,000 shares at $15.84 per share on June 18, 2026 and 5,000 shares at $14.88 per share on June 19, 2026, for total sales of 10,000 shares. Following these transactions, he directly owns 210,094 shares of Common Stock, and the exercised derivative position is fully converted with no remaining derivative holdings reported.
Richard Horowitz submitted a Form 144 notice reporting proposed sales of common stock and disclosing a sale of 67,500 shares on 05/18/2026 for $1,221,735.29. The filing lists multiple past open‑market transactions and several equity compensation issuances with discrete share counts.
Trio-Tech International director Jason T. Adelman exercised stock options to acquire additional common shares. He exercised rights to buy 70,094 shares of common stock at an exercise price of $2.57 per share and 40,000 shares at $3.88 per share.
Following these option exercises, the Form 4 shows direct holdings of 150,094 common shares in one line item and 80,000 common shares in another, reflecting his updated reported ownership from the respective grants, with no sales reported in this filing.
TRIO-TECH INTERNATIONAL director Ting Hock Ming reported an open-market sale of 17,200 shares of TRT Common Stock on May 26, 2026. The shares were sold at a weighted average price of $16.65, across individual trades between $16.21 and $17.22 per share.
After this transaction, Ting Hock Ming directly owns 131,044 shares of Trio-Tech International. This filing reflects a partial reduction of his position while retaining a substantial remaining stake in the company.
TRIO-TECH INTERNATIONAL director and 10% owner Richard M. Horowitz reported an open-market sale of 67,500 shares of Common Stock. The sale took place on May 18, 2026 at a weighted average price of $18.1003 per share, with individual trades ranging from $18.10 to $18.13.
After this transaction, Horowitz directly holds 664,784 shares of TRIO-TECH INTERNATIONAL Common Stock. The filing notes that detailed trade-by-trade pricing within the reported range is available upon request from the issuer, security holders, or the SEC staff.
TRIO-TECH INTERNATIONAL director Jason T. Adelman reported a mix of option exercise and share sales. On May 18, 2026, he exercised options for 39,750 shares of common stock at $2.25 per share, converting a derivative position into stock. He then sold a total of 49,975 shares of common stock in open-market transactions on May 18–19, 2026 at prices between $13.97 and $18.76 per share. After these transactions, he held 40,000 shares of Trio-Tech common stock directly.